Skip to main content

Animations

MJFF Publications

3221 - 3230 of 6230 Results
Title
Year
  • Year
  • 2022
  • 2020
  • 2017
  • 2019
  • 2024
  • 2021
  • 2015
  • 2017
  • 2024
  • 2016
  • Summary Details
    OPEN
    Title: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jex2.59
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51146
    Citation Count: 54
  • Summary Details
    OPEN
    Title: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2019.05.064
    Citation Count: 308
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202114022
    Citation Count: 171
  • Summary Details
    OPEN
    Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018
    Citation Count: 244
  • Summary Details
    OPEN
    Title: An invisible ubiquitin conformation is required for efficient phosphorylation by PINK 1
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.15252/embj.201797876
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Predictors of stress resilience in Parkinson’s disease and associations with symptom progression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00692-4
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2016.02.012
    Citation Count: 72
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.